top
Search terms
Results 1 - 3 of 3 - ordered by :
Ehjcvp

Abstract Aims We compared clinical outcomes in patients with AF with and without diabetes in the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Justin A. Ezekowitz, Basil S. Lewis, Renato D. Lopes, Daniel M. Wojdyla, John J.V. McMurray, Michael Hanna, Dan Atar, M. ...

Date : 01/04/2015 Item size : 304584 bytes
Ehjcvp

Oral anticoagulation (OAC) is recommended for patients with atrial fibrillation (AF) who are at risk of stroke.1 The CHA2DS2-VASc score, which encompassed a group of common co-morbidities for ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Jo Jo Hai, Hung-Fat Tse

Date : 01/04/2015 Item size : 156814 bytes
Ehjcvp

Anti-coagulantAnti-plateletAtrial fibrillationBleeding,HaemorrhageNovel oral anti-coagulantStrokeVitamin K antagonistIntroduction In patients with atrial fibrillation (AF), Vitamin K antagonists ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Ariel Dogliotti, Robert P. Giugliano

Date : 01/01/2015